Condition: Parkinson's · Parkinson Disease · Parkinson's Disease · Sponsor: University of Exeter
In this study, the researchers aim to find a biomarker of PD. Using imaging scans called Positron Emission tomography (PET), Single Photon Emission Computed Tomography (SPECT), and Magnetic Resonance Imaging (MRI). The PET and SPECT scans use small amounts of radiation and specific compounds called tracers, to study chemical changes in the brain in a way not possible with any other procedure. The MRI uses magnetic fields to generate images of brain structure and function
This description comes directly from the study's public registry record.
Marios Politis, Professor · 07503741242 · M.Politis@exeter.ac.uk
Edoardo de Natale, Dr · 07503741242 · e.de-natale@exeter.ac.uk
Always discuss trial participation with your own doctor first.
| University Of Exeter | Exeter, Devon, United Kingdom | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05516719